Cargando…
Development of a Novel Immune-Related Gene Signature to Predict Prognosis and Immunotherapeutic Efficiency in Gastric Cancer
Background: Gastric cancer (GC) is the fifth most common malignancy and the third leading cause of tumor-related deaths globally. Herein, we attempted to build a novel immune-related gene (IRG) signature that could predict the prognosis and immunotherapeutic efficiency for GC patients. Methods: The...
Autores principales: | Liu, Dongliang, Xu, Yuanmin, Fang, Yu, Hu, Kongwang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186121/ https://www.ncbi.nlm.nih.gov/pubmed/35692814 http://dx.doi.org/10.3389/fgene.2022.885553 |
Ejemplares similares
-
Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer
por: Xu, Jingxuan, et al.
Publicado: (2021) -
An Immune-Related Gene Signature Can Predict Clinical Outcomes and Immunotherapeutic Response in Oral Squamous Cell Carcinoma
por: Zhang, Liyuan, et al.
Publicado: (2022) -
Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Lianghao, et al.
Publicado: (2021) -
A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancer
por: Zhang, Zhihao, et al.
Publicado: (2022) -
Identification of a Novel Immune-Related CpG Methylation Signature to Predict Prognosis in Stage II/III Colorectal Cancer
por: Chen, Feng, et al.
Publicado: (2021)